<qa>  Prior treatment with EGFR targeting therapies or treatment with EGFR- or HER2- Prior treatment with EGFR targeting therapies or treatment with EGFR- or HER2 inhibiting drugs within the past 4 weeks before start of therapy or concomitantly with this trial 